Effect of lactate accumulation on translation and transcription in MDA-MB-231 breast cancer cells
RNA-seq (gene expression) · human · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 12 samples: 3 × total RNA, MDA-MB-231 cells, DMSO, vs 3 × total RNA, MDA-MB-231 cells, AZD0095, vs 3 × Ribosome protected fragments, MDA-MB-231 cells, DMSO, vs 3 × Ribosome protected fragments, MDA-MB-231 cells, AZD0095,Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE297242_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1263382 and SRA study SRP586076. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 4 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8986684 total RNA, MDA-MB-231 cells, DMSO, replicate 1 total RNA, MDA-MB-231 c…
- GSM8986685 total RNA, MDA-MB-231 cells, DMSO, replicate 2 total RNA, MDA-MB-231 c…
- GSM8986686 total RNA, MDA-MB-231 cells, DMSO, replicate 3 total RNA, MDA-MB-231 c…
- GSM8986687 total RNA, MDA-MB-231 cells, AZD0095, replicate 1 total RNA, MDA-MB-231 c…
- GSM8986688 total RNA, MDA-MB-231 cells, AZD0095, replicate 2 total RNA, MDA-MB-231 c…
- GSM8986689 total RNA, MDA-MB-231 cells, AZD0095, replicate 3 total RNA, MDA-MB-231 c…
- GSM8986690 Ribosome protected fragments, MDA-MB-231 cells, DMSO, replicate 1 Ribosome protected frag…
- GSM8986691 Ribosome protected fragments, MDA-MB-231 cells, DMSO, replicate 2 Ribosome protected frag…
- GSM8986692 Ribosome protected fragments, MDA-MB-231 cells, DMSO, replicate 3 Ribosome protected frag…
- GSM8986693 Ribosome protected fragments, MDA-MB-231 cells, AZD0095, replicate 1 Ribosome protected frag…
- GSM8986694 Ribosome protected fragments, MDA-MB-231 cells, AZD0095, replicate 2 Ribosome protected frag…
- GSM8986695 Ribosome protected fragments, MDA-MB-231 cells, AZD0095, replicate 3 Ribosome protected frag…
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares translation, breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares transcription, breast
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE303576 Rb-driven transcription limits its tumour suppressive effects in breast cancer 279 samples shares transcription, breast
- GSE259248 ZBTB7A is a modulator of KDM5-driven transcriptional networks in basal breast cancer (ChIP-Seq) 36 samples shares transcription, breast
- GSE281556 Lysosomal sequestration of PARP inhibitors drives heterogeneous accumulation in ovarian cancer to increase efficacy 204 samples shares accumulation
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.